Synopsis
Synopsis
0
JDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)ethanol
2. Atarax
3. Durrax
4. Hydroxyzine
5. Hydroxyzine Dihydrochloride
6. Hydroxyzine Pamoate
7. Orgatrax
8. Pamoate, Hydroxyzine
9. Vistaril
1. Hydroxyzine Hcl
2. 1244-76-4
3. Hydroxyzine Monohydrochloride
4. Ca67jf5q4w
5. Mls000028602
6. Smr000058737
7. 2-(2-(4-((4-chlorophenyl)phenylmethyl)piperazin-1-yl)ethoxy)ethanol Hydrochloride
8. 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol;hydrochloride
9. 2-[2-[4-[(4-chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]ethanol Hydrochloride
10. Einecs 214-989-3
11. Unii-ca67jf5q4w
12. Hydroxyzin Hydrochloride
13. Opera_id_1515
14. 1-(p-chlorobenzhydryl)-4-(2-(2-hydroxyethoxy)ethyl)diethylenediamine Hydrochloride
15. Dsstox_cid_27530
16. Dsstox_rid_82400
17. Dsstox_gsid_47530
18. Schembl41448
19. Mls002222192
20. Chembl1201007
21. Dtxsid5047530
22. Tox21_302563
23. Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, Monohydrochloride
24. Ethanol, 2-(2-(4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)-, Hydrochloride
25. Ethanol, 2-(2-(4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)-, Monohydrochloride
26. Ncgc00180974-01
27. Ncgc00256629-01
28. 14729-22-7
29. Cas-1244-76-4
30. Q27275377
31. 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol;hydron;chloride
32. 2-[2-[4-[(4-chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]ethanolhydrochloride
33. Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, Hydrochloride (1:1)
34. Ethanol, 2-(2-(4-(p-chloro-.alpha.-phenylbenzyl)-1-piperazinyl)ethoxy)-, Monohydrochloride
| Molecular Weight | 411.4 g/mol |
|---|---|
| Molecular Formula | C21H28Cl2N2O2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 8 |
| Exact Mass | 410.1527835 g/mol |
| Monoisotopic Mass | 410.1527835 g/mol |
| Topological Polar Surface Area | 35.9 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 376 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antipruritics
Agents, usually topical, that relieve itching (pruritus). (See all compounds classified as Antipruritics.)
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
Certificate Number : CEP 2021-436 - Rev 00
Status : Valid
Issue Date : 2024-10-08
Type : Chemical
Substance Number : 916
Certificate Number : CEP 2022-318 - Rev 00
Status : Valid
Issue Date : 2024-06-05
Type : Chemical
Substance Number : 916
Certificate Number : CEP 2010-076 - Rev 04
Status : Valid
Issue Date : 2025-04-25
Type : Chemical
Substance Number : 916
Certificate Number : CEP 2016-056 - Rev 01
Status : Valid
Issue Date : 2024-10-16
Type : Chemical
Substance Number : 916
Certificate Number : R1-CEP 2015-186 - Rev 00
Status : Valid
Issue Date : 2021-07-12
Type : Chemical
Substance Number : 916
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Certificate Number : CEP 2024-075 - Rev 00
Status : Valid
Issue Date : 2025-05-16
Type : Chemical
Substance Number : 916
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - 25MG/ML **Fed...DOSAGE - INJECTABLE;INJECTION - 25MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 11111
DOSAGE - INJECTABLE;INJECTION - 50MG/ML **Fed...DOSAGE - INJECTABLE;INJECTION - 50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 11111
DOSAGE - SYRUP;ORAL - 10MG/5ML
USFDA APPLICATION NUMBER - 87294
DOSAGE - INJECTABLE;INJECTION - 25MG/ML
USFDA APPLICATION NUMBER - 87408
DOSAGE - INJECTABLE;INJECTION - 50MG/ML
USFDA APPLICATION NUMBER - 87408
DOSAGE - TABLET;ORAL - 25MG
USFDA APPLICATION NUMBER - 88618
DOSAGE - TABLET;ORAL - 50MG
USFDA APPLICATION NUMBER - 88619
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
77
PharmaCompass offers a list of Hydroxyzine Dihydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hydroxyzine Dihydrochloride manufacturer or Hydroxyzine Dihydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hydroxyzine Dihydrochloride manufacturer or Hydroxyzine Dihydrochloride supplier.
PharmaCompass also assists you with knowing the Hydroxyzine Dihydrochloride API Price utilized in the formulation of products. Hydroxyzine Dihydrochloride API Price is not always fixed or binding as the Hydroxyzine Dihydrochloride Price is obtained through a variety of data sources. The Hydroxyzine Dihydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Hydroxyzine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hydroxyzine Hydrochloride, including repackagers and relabelers. The FDA regulates Hydroxyzine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hydroxyzine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hydroxyzine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hydroxyzine Hydrochloride supplier is an individual or a company that provides Hydroxyzine Hydrochloride active pharmaceutical ingredient (API) or Hydroxyzine Hydrochloride finished formulations upon request. The Hydroxyzine Hydrochloride suppliers may include Hydroxyzine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Hydroxyzine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Hydroxyzine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Hydroxyzine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Hydroxyzine Hydrochloride DMFs exist exist since differing nations have different regulations, such as Hydroxyzine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Hydroxyzine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Hydroxyzine Hydrochloride USDMF includes data on Hydroxyzine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Hydroxyzine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Hydroxyzine Hydrochloride suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Hydroxyzine Hydrochloride Drug Master File in Korea (Hydroxyzine Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Hydroxyzine Hydrochloride. The MFDS reviews the Hydroxyzine Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Hydroxyzine Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Hydroxyzine Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Hydroxyzine Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Hydroxyzine Hydrochloride suppliers with KDMF on PharmaCompass.
A Hydroxyzine Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Hydroxyzine Hydrochloride Certificate of Suitability (COS). The purpose of a Hydroxyzine Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Hydroxyzine Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Hydroxyzine Hydrochloride to their clients by showing that a Hydroxyzine Hydrochloride CEP has been issued for it. The manufacturer submits a Hydroxyzine Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Hydroxyzine Hydrochloride CEP holder for the record. Additionally, the data presented in the Hydroxyzine Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Hydroxyzine Hydrochloride DMF.
A Hydroxyzine Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Hydroxyzine Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Hydroxyzine Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Hydroxyzine Hydrochloride written confirmation (Hydroxyzine Hydrochloride WC) is an official document issued by a regulatory agency to a Hydroxyzine Hydrochloride manufacturer, verifying that the manufacturing facility of a Hydroxyzine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Hydroxyzine Hydrochloride APIs or Hydroxyzine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Hydroxyzine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Hydroxyzine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Hydroxyzine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Hydroxyzine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Hydroxyzine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Hydroxyzine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Hydroxyzine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Hydroxyzine Hydrochloride suppliers with NDC on PharmaCompass.
Hydroxyzine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hydroxyzine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hydroxyzine Hydrochloride GMP manufacturer or Hydroxyzine Hydrochloride GMP API supplier for your needs.
A Hydroxyzine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Hydroxyzine Hydrochloride's compliance with Hydroxyzine Hydrochloride specifications and serves as a tool for batch-level quality control.
Hydroxyzine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Hydroxyzine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hydroxyzine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Hydroxyzine Hydrochloride EP), Hydroxyzine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hydroxyzine Hydrochloride USP).
